article thumbnail

Q&A: Looking ahead at digital health, biotech funding in 2023

Mobi Health News

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

BioTech 361
article thumbnail

List of Digital Health, Healthcare IT and MedTech conferences in 2023

Digital Health Hub

Is your 2023 calendar filling up? Here are some digital health events scheduled for 2023. If you are a digital health event organizer, and want to feature your event here, please contact here. Click on the links to visit the event homepage and also to access the schedule. Last Update : Dec 6,2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

List of Digital Health, Healthcare IT and MedTech conferences in 2023

Digital Health Hub

Is your 2023 calendar filling up? Here are some digital health events scheduled for 2023. Click on the links to visit the event homepage and also to access the schedule.

article thumbnail

February 2024: selected Women’s Health updates

Digital Health Global

The first promising results from the clinical trial of the first non-hormonal, non-surgical treatment for endometriosis started in 2023 in Scotland, plus my deep dive into the endometriosis area. Meanwhile, innovations like Hera Biotech’s non-invasive test and Ziwig Biotech’s saliva test offer hope for a quicker diagnosis.

BioTech 167
article thumbnail

Global OTC/DTC Infectious Disease Diagnostic Market 2023 to 2027

Digital Health Global

Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Scanwell Health moves beyond home UTI testing 6.34 Tasso scores $6.1M

BioTech 88
article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

article thumbnail

SpringTide Ventures Announces the Close of $65 Million Fund II

Digital Health Global

This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, life sciences, and tech-enabled care delivery. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.